Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Cochrane and the new McCarthyism.

Jefferson T.

Indian J Med Ethics. 2019 Jan-Mar;4(1):82-83. doi: 10.20529/IJME.2018.094. Epub 2018 Nov 24.

2.

When to include clinical study reports and regulatory documents in systematic reviews.

Jefferson T, Doshi P, Boutron I, Golder S, Heneghan C, Hodkinson A, Jones M, Lefebvre C, Stewart LA.

BMJ Evid Based Med. 2018 Dec;23(6):210-217. doi: 10.1136/bmjebm-2018-110963. Epub 2018 Oct 11.

PMID:
30309870
3.

Challenges of independent assessment of potential harms of HPV vaccines.

Jørgensen L, Doshi P, Gøtzsche P, Jefferson T.

BMJ. 2018 Sep 24;362:k3694. doi: 10.1136/bmj.k3694. No abstract available.

PMID:
30249615
4.

The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors.

Hodkinson A, Dietz KC, Lefebvre C, Golder S, Jones M, Doshi P, Heneghan C, Jefferson T, Boutron I, Stewart L.

Syst Rev. 2018 Aug 8;7(1):117. doi: 10.1186/s13643-018-0766-x.

5.

The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias.

Jørgensen L, Gøtzsche PC, Jefferson T.

BMJ Evid Based Med. 2018 Oct;23(5):165-168. doi: 10.1136/bmjebm-2018-111012. Epub 2018 Jul 27. No abstract available.

PMID:
30054374
6.

What is a 'complex systematic review'? Criteria, definition, and examples.

Mahtani KR, Jefferson T, Heneghan C, Nunan D, Aronson JK.

BMJ Evid Based Med. 2018 Aug;23(4):127-130. doi: 10.1136/bmjebm-2018-110965. Epub 2018 May 19. No abstract available.

PMID:
29778991
7.

Restoring biomedical literature with RIAT.

Doshi P, Shamseer L, Jones M, Jefferson T.

BMJ. 2018 Apr 26;361:k1742. doi: 10.1136/bmj.k1742. No abstract available.

PMID:
29700000
8.

[Redefining the 'E' in EBM.]

Jefferson T, Jørgensen L.

Recenti Prog Med. 2018 Apr;109(4):211-213. doi: 10.1701/2896.29190. Italian.

PMID:
29689034
9.

Redefining the 'E' in EBM.

Jefferson T, Jørgensen L.

BMJ Evid Based Med. 2018 Apr;23(2):46-47. doi: 10.1136/bmjebm-2018-110918. Epub 2018 Mar 9. No abstract available.

PMID:
29595127
10.

Vaccines for preventing influenza in the elderly.

Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, Rivetti A.

Cochrane Database Syst Rev. 2018 Feb 1;2:CD004876. doi: 10.1002/14651858.CD004876.pub4. Review.

11.

Vaccines for preventing influenza in healthy adults.

Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C.

Cochrane Database Syst Rev. 2018 Feb 1;2:CD001269. doi: 10.1002/14651858.CD001269.pub6. Review.

12.

Vaccines for preventing influenza in healthy children.

Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V.

Cochrane Database Syst Rev. 2018 Feb 1;2:CD004879. doi: 10.1002/14651858.CD004879.pub5. Review.

14.

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.

Heneghan CJ, Goldacre B, Onakpoya I, Aronson JK, Jefferson T, Pluddemann A, Mahtani KR.

BMJ Open. 2017 Dec 6;7(12):e017125. doi: 10.1136/bmjopen-2017-017125. Review.

15.

Sticking to principles and anticipating outcomes.

Jefferson T.

J R Soc Med. 2017 Nov;110(11):458-459. doi: 10.1177/0141076817737972. Epub 2017 Oct 16. No abstract available.

PMID:
29035670
16.

Sticking to principles and anticipating outcomes.

Jefferson T.

Recenti Prog Med. 2017 Sep;108(9):347-349. doi: 10.1701/2745.27983. Italian.

PMID:
28901340
17.

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.

Doshi P, Hur P, Jones M, Albarmawi H, Jefferson T, Morgan DJ, Spears PA, Powers JH 3rd.

JAMA Intern Med. 2017 Oct 1;177(10):1452-1459. doi: 10.1001/jamainternmed.2017.3820.

18.

[Plagiarism. A fools' errand.]

Jefferson T, De Fiore L.

Recenti Prog Med. 2017 Jan;108(1):7-10. doi: 10.1701/2624.26978. Italian.

PMID:
28151522
20.

"Adaptive pathways" to drug authorisation: adapting to industry?

Davis C, Lexchin J, Jefferson T, Gøtzsche P, McKee M.

BMJ. 2016 Aug 16;354:i4437. doi: 10.1136/bmj.i4437. No abstract available.

21.

The neuraminidase inhibitors evidence of harms - in context.

Jefferson T.

Infect Dis (Lond). 2016 Sep;48(9):661-2. doi: 10.1080/23744235.2016.1189593. No abstract available.

PMID:
27347711
22.

Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions.

Thomas RE, Jefferson T, Lasserson TJ.

Cochrane Database Syst Rev. 2016 Jun 2;(6):CD005187. doi: 10.1002/14651858.CD005187.pub5. Review.

PMID:
27251461
23.

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.

Heneghan CJ, Onakpoya I, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Mahtani KR, Nunan D, Howick J, Jefferson T.

Health Technol Assess. 2016 May;20(42):1-242. doi: 10.3310/hta20420. Review.

24.

Neuraminidase Inhibitors and Influenza Infection.

Doshi P, Jefferson T.

JAMA Intern Med. 2016 Mar;176(3):415-6. doi: 10.1001/jamainternmed.2016.0016. No abstract available.

PMID:
26954053
25.

Is the timing of recommended childhood vaccines evidence based?

Edwards KM, Maldonado Y, Byington CL, Jefferson T, Demicheli V.

BMJ. 2016 Feb 23;352:i867. doi: 10.1136/bmj.i867. No abstract available.

PMID:
26907183
26.

[Facing the unreliability of clinical trials literature].

Jefferson T.

Recenti Prog Med. 2016 Jan;107(1):10-8. doi: 10.1701/2132.23098. Italian.

PMID:
26901365
27.
28.

Oseltamivir for influenza.

Doshi P, Heneghan C, Jefferson T.

Lancet. 2016 Jan 9;387(10014):124. doi: 10.1016/S0140-6736(15)01282-9. Epub 2016 Jan 8. No abstract available.

PMID:
26841993
29.

Oseltamivir for influenza.

Doshi P, Heneghan C, Jefferson T.

Lancet. 2015 Sep 19;386(9999):1134-5. doi: 10.1016/S0140-6736(15)00202-0. No abstract available.

PMID:
26461899
30.

Collaborative models for the joint production of core health technology assessments: negative and positive aspects for the joint work of different European agencies.

Lo Scalzo A, Vicari N, Corio M, Perrini MR, Jefferson T, Gillespie F, Cerbo M.

Int J Technol Assess Health Care. 2014 Nov;30(5):536-43. doi: 10.1017/S026646231400066X.

PMID:
25747564
31.

The evidence base for new drugs.

Doshi P, Jefferson T.

BMJ. 2015 Mar 2;350:h952. doi: 10.1136/bmj.h952. No abstract available.

PMID:
25731767
32.

Safety and efficacy of inactivated influenza vaccines in children.

Collignon P, Doshi P, Del Mar C, Jefferson T.

Clin Infect Dis. 2015 Feb 1;60(3):489. doi: 10.1093/cid/ciu835. Epub 2014 Oct 23. No abstract available.

PMID:
25344541
33.

Neuraminidase inhibitors for influenza complications.

Del Mar C, Doshi P, Hama R, Jones M, Jefferson T, Heneghan C, Onakpoya I, Howick J.

Lancet. 2014 Oct 4;384(9950):1260-1. doi: 10.1016/S0140-6736(14)61761-X. No abstract available.

PMID:
25283565
34.

Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Onakpoya I, Heneghan CJ.

BMJ Open. 2014 Sep 30;4(9):e005253. doi: 10.1136/bmjopen-2014-005253.

35.

[Multisystem failure: the story of antinfluenza drugs].

Jefferson T, Doshi P.

Recenti Prog Med. 2014 May;105(5):187-90. doi: 10.1701/1493.16451. Review. Italian.

PMID:
24873941
36.

Clinical trials: Tamiflu reviewers respond to critics.

Doshi P, Jefferson T.

Nature. 2014 May 15;509(7500):288. doi: 10.1038/509288a. No abstract available.

PMID:
24828182
37.

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T.

BMJ. 2014 Apr 9;348:g2547. doi: 10.1136/bmj.g2547. Review.

38.

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ.

BMJ. 2014 Apr 9;348:g2545. doi: 10.1136/bmj.g2545. Review.

39.

Authors' reply to Dunning.

Doshi P, Jefferson T.

BMJ. 2014 Apr 30;348:g3018. doi: 10.1136/bmj.g3018. No abstract available.

PMID:
24788245
40.

Multisystem failure: the story of anti-influenza drugs.

Jefferson T, Doshi P.

BMJ. 2014 Apr 10;348:g2263. doi: 10.1136/bmj.g2263. No abstract available.

PMID:
24721793
41.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ.

Cochrane Database Syst Rev. 2014 Apr 10;(4):CD008965. doi: 10.1002/14651858.CD008965.pub4. Review.

42.

Vaccines for preventing influenza in healthy adults.

Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C.

Cochrane Database Syst Rev. 2014 Mar 13;(3):CD001269. doi: 10.1002/14651858.CD001269.pub5. Update in: Cochrane Database Syst Rev. 2018 Feb 01;2:CD001269.

PMID:
24623315
43.

Implantable devices for the closure of patent foramen ovale in adults: an Italian rapid health technology assessment.

Migliore A, Jefferson T, Cerbo M, Abraha I, Montedori A.

Expert Rev Med Devices. 2014 Mar;11(2):151-61. doi: 10.1586/17434440.2014.882229. Review.

PMID:
24506299
44.

Increasing value and reducing waste: addressing inaccessible research.

Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, Krumholz HM, Ghersi D, van der Worp HB.

Lancet. 2014 Jan 18;383(9913):257-66. doi: 10.1016/S0140-6736(13)62296-5. Epub 2014 Jan 8.

45.

[Influenza vaccination for healthcare workers who work with the elderly].

Thomas RE, Jefferson T, Lasseron TJ.

Arch Prev Riesgos Labor. 2013 Jul-Sep;16(3):136-7. Spanish. No abstract available.

PMID:
23930270
46.

Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions.

Thomas RE, Jefferson T, Lasserson TJ.

Cochrane Database Syst Rev. 2013 Jul 22;(7):CD005187. doi: 10.1002/14651858.CD005187.pub4. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD005187.

PMID:
23881655
47.

Restoring invisible and abandoned trials: a call for people to publish the findings.

Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T.

BMJ. 2013 Jun 13;346:f2865. doi: 10.1136/bmj.f2865. No abstract available. Erratum in: BMJ. 2013;346:f4223.

48.

The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer.

Doshi P, Jefferson T.

JAMA Intern Med. 2013 Mar 11;173(5):380-2. No abstract available.

PMID:
23599918
49.

Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports.

Doshi P, Jefferson T.

BMJ Open. 2013 Feb 26;3(2). pii: e002496. doi: 10.1136/bmjopen-2012-002496. Print 2013.

50.

Influenza vaccination of health care workers.

Doshi P, Abi-Jaoude E, Lexchin J, Jefferson T, Thomas RE.

CMAJ. 2013 Feb 5;185(2):150. doi: 10.1503/cmaj.113-2096. No abstract available.

Supplemental Content

Loading ...
Support Center